Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer

Lung Cancer

Volumn 52, Issue 2, 2006, Pages 181-187

  Shirai, Takao ^a   Hirose, Takashi ^a   Noda, Munehide ^a   Ando, Kouichi ^a   Ishida, Hiroo ^a   Hosaka, Takamichi ^a   Ozawa, Tetsuzi ^a   Okuda, Kentarou ^a   Ohnishi, Tsukasa ^a   Ohmori, Tohru ^a   Horichi, Naoya ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Age; Gemcitabine; Metastasis; Nedaplatin; Non small cell lung cancer; Phase II study; PS

Indexed keywords

AMINOTRANSFERASE; DEXAMETHASONE; GEMCITABINE; NEDAPLATIN; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; INFECTION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; RIBONUCLEOTIDE REDUCTASES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645959226     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.01.004     Document Type: Article

References (42)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311 (1995) 899-909
2. Kaye S.B. Gemcitabine: current status of phases I and II trials. J Clin Oncol 12 (1994) 1527-1531
3. Sandler A., and Ettinger D. Gemcitabine: single agent and combination therapy in non-small cell lung cancer. Oncologist 4 (1999) 241-251
4. Crino L., Scagliotti G., and Marangolo M. Cisplatin-gemcitabine combination in advanced non-small-cell-lung cancer: a phase II study. J Clin Oncol 15 (1997) 297-303
5. Abratt R.P., Bezwoda W.R., and Goedhals L. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 15 (1997) 744-749
6. Steward W.P., Dunlop D.J., and Dabouis G. PhaseI/II study of gemcitabine and cisplatin in non-small-cell lung cancer: preliminary results. Semin Oncol 5 Suppl. 10 (1996) 43-47
7. Anton A., Atrial A., and Carrato A. Gemcitabine plus cisplatin in advanced NSCLC: final phase II results. Proc Am Soc Clin Oncol 16 (1997) 461
8. Jassem J., Krzakowski M., and Roszkowski K. A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. Lung Cancer 35 (2002) 73-79
9. Carrato A., Garcia-Gomez J., and Alberola V. Carboplatin(CARBO) in combination with gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). Comparison of two consecutive phase II trials using different schedules. Proc Am Soc Clin Oncol 18 (1999) 498a
10. Edelman M.J., Gandara D.R., and Lau D. Sequential carboplatin/gemcitabine(C/G) → paclitaxel (P) in advanced non-small cell lung cancer (NSCLC): an effective and well tolerated regimen. Proc Am Soc Clin Oncol 18 (1999) 502a
11. Sederholm C. A phase II study of gemcitabine plus carboplatin in chemonative patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 18 (1999) 490a
12. Carrato A., Alberto V., and Massuti B. Combination of gemcitabine (GEM) and carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC). Ann Oncol 9 Suppl. 4 (1998) 89
13. Iaffaioli R.V., Tortoriello A., and Facchini G. Phase I/II study of gemcitabine and carboplatin in stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 17 (1999) 921-926
14. Shiratori O., Kanai H., and Uchida N. Antitumor activity of 254-S, a platinum complex, in rodents. In: Ishigami J. (Ed). Recent advances in chemotherapy (1985), University of Tokyo Press, Tokyo 635-636
15. Fukuda M., Shinkai T., and Eguchi K. Phase II study of (glycolate-O,O′) diammineplatium(II), a novel platinum complex, in the treatment of non-small cell lung cancer. Cancer Chemother Pharmacol 26 (1990) 393-396
16. Furuse K., Fukuoka M., and Kurita Y. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer. Jpn J Cancer Chemother 19 (1992) 879-884
17. Furuse K., Fukuoka M., and Asamoto H. A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin plus VDS in patients with advanced non-small cell lung cancer. Jpn J Cancer Chemother 19 (1992) 1019-1026
18. Matsumoto M., Takeda Y., and Maekawa R. Combination chemotherapy of gemcitabine with nedaplatin. J New Rem Clin 5 (2000) 484-490
19. Hirose T., Horichi N., and Ohmori T. Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer. Lung cancer 39 (2003) 91-97
20. Kurata T., Tamura K., and Yamamoto N. Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer. Br J cancer 90 (2004) 2092-2096
21. World Health Organization. WHO handbook for reporting results of cancer treatment vol. 48 (1979), WHO offset publication, Geneva, Switzerland
22. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
23. Schiller J.H., Harrington D., and Belani C.P. Comparison of four chemotherapy regimen for advanced non-small-cell lung cancer. N Engl J Med 346 (2002) 92-98
24. Kelly K., Crowley J., and Burn Jr. P.A. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell-lung-cancer: A Southwest Oncology Group trial. J Clin Oncol 19 (2001) 3210-3218
25. Smit E.F., Meerbeeck J.P., and Lianes P. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 21 (2003) 3909-3917
26. Scagliotti G.V., Marinis F., and Rinaldi M. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 20 (2002) 4285-4291
27. Rudd R.M., Gpwer N.H., and Spiro S.G. Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London lung cancer group. J Clin Oncol 23 (2005) 142-153
28. Zatloukal P., Petruzelka L., and Zemanova M. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIB and IV non-small-cell lung cancer: a phase III randomized trial. Lung Cancer 41 (2003) 321-331
29. Giaccone G., Herbst R.S., and Manegold C. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: phase III trial-INTACT 1. J Clin Oncol 22 (2004) 777-784
30. Herbst R.S., Giaccone G., and Schiller J.H. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 2. J Clin Oncol 22 (2004) 785-794
31. Hoang T., Xu R., and Shiller J.H. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimen based on Eastern Cooperative Oncology Group Data. J Clin Oncol 23 (2005) 175-183
32. Klastersky J., Sculier J.P., and Lacroix H. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European organization for research and treatment of cancer protocol 07861. J Clil Oncol 8 (1990) 1556-1562
33. Inuyama Y., Miyake H., and Horiuchi M. A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers. Jpn J cancer chemother 19 (1992) 871-877
34. Yamamoto N., Tamura T., and Kurata T. Phase I and pharmacokinetic (PK) study of (glycolate-O,O′)-diammine platinum(II) (Nedaplatin: 254-S) in elderly patients with non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 19 (2000) 203a
35. Sweeney J.C., Zhu J., and Sandler A.B. Outcome of patients with a performance status of 2 in Eastern cooperative oncology group study E1594. A phase III trial in patients with metastatic nonsmall cell lung carcinoma. Cancer 92 (2001) 2639-2647
36. Soria J.C., Brisgand D., and Le Chevalier T. Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?. Ann Oncol 12 (2001) 1667-1670
37. Pfister D.G., Jhonson D.H., and Azzoli C.G. American Society of Clinical Oncology treatment non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
38. Gridelli C., Ardizzoni A., and Le Chevalier T. Treatment of advanced non-small-cell lung cancer patients with ECOG perfomance status 2: results of an European experts panel. Ann Oncol 15 (2004) 419-426
39. Lilenbaum R.C., Herndon II J.E., and List M.A. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 23 (2005) 190-196
40. Gridelli C., Perrone F., and Gallo C. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the elderly study (MILES) phase III randomized trial. J Natl Cancer Inst 95 (2003) 362-372
41. Langer C.J., Manola J., and Bernardo P. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of eastern cooperative oncology group 5592, a randomized trial. J Natl Cancer Inst 94 (2002) 173-181
42. Bunn P.A., and Lilenbaum R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 95 (2003) 341-343